Fargesin

CAS : 31008-19-2

Ref. 3D-FF41812

Informations sur le produit

• Nom: Fargesin
• Synonymes: 1,3-Benzodioxole, 5-[(1R,3aS,4S,6aS)-4-(3,4-dimethoxyphenyl)tetrahydro-1H,3H-furo[3,4-c]furan-1-yl]-, rel-, 1,3-Benzodioxole, 5-[4-(3,4-dimethoxyphenyl)tetrahydro-1H,3H-furo[3,4-c]furan-1-yl]-, (1α,3aα,4β,6aα)-, 1,3-benzodioxole, 5-[(1S,3aR,4R,6aR)-4-(3,4-dimethoxyphenyl)tetrahydro-1H,3H-furo[3,4-c]furan-1-yl]-, 1H,3H-Furo[3,4-c]furan, 1,3-benzodioxole deriv., 1H,3H-Furo[3,4-c]furan, 1α-(3,4-dimethoxyphenyl)-3aβ,4,6,6aβ-tetrahydro-4β-[(3,4-methylenedioxy)phenyl]-, 5-[(1S,3aR,4R,6aR)-4-(3,4-Dimethoxyphenyl)tetrahydro-1H,3H-furo[3,4-c]furan-1-yl]-1,3-benzodioxole, rel-5-[(1R,3aS,4S,6aS)-4-(3,4-Dimethoxyphenyl)tetrahydro-1H,3H-furo[3,4-c]furan-1-yl]-1,3-benzodioxole

Description

Fargesin is a drug that inhibits the function of specific protein targets, such as drug transporters. It has been shown to reduce bowel disease in animal models by inhibiting the inflammatory response and reducing lipid uptake by macrophages. Fargesin also has an effect on the matrix of atherosclerotic lesions, reducing calcification and fibrosis. The physiologic effects of fargesin are related to its ability to inhibit enzymes that regulate cellular processes, including protein synthesis, lipolysis, and coagulation. Fargesin is an antimicrobial agent that is active against a wide range of microorganisms including fungi and bacteria.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 370.4 g/mol
• Formule: C₂₁H₂₂O₆
• Degré de pureté: Min. 95%
• Couleur/Forme: Powder
• InChI: InChI=1S/C21H22O6/c1-22-16-5-3-12(7-18(16)23-2)20-14-9-25-21(15(14)10-24-20)13-4-6-17-19(8-13)27-11-26-17/h3-8,14-15,20-21H,9-11H2,1-2H3/t14-,15-,20-,21+/m0/s1
• Code InChI: InChIKey=AWOGQCSIVCQXBT-LATRNWQMSA-N
• SMILES: COc1ccc([C@@H]2OC[C@@H]3[C@@H](c4ccc5c(c4)OCO5)OC[C@H]23)cc1OC